Insulet News - May 26, 2026

Insulet's Omnipod Recall Rattles Investors — But Can the Company Really Absorb a $50 Million Hit Without Missing a Beat?

Shares of Insulet Corporation plunged 8.4% after hours to $140.89, erasing a week of steady gains, after the insulin-pump maker disclosed a voluntary...

Insulet Announces Voluntary Omnipod Correction, Expects Up to $50M in Costs

Insulet Corporation announced a voluntary Medical Device Correction for specific lots of its Omnipod products due to a manufacturing issue that could lead to...